rs587777556
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001040151.2(SCN3B):c.389C>T(p.Ala130Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,614,036 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A130A) has been classified as Benign.
Frequency
Consequence
NM_001040151.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN3B | NM_001040151.2 | c.389C>T | p.Ala130Val | missense_variant | Exon 4 of 7 | ENST00000299333.8 | NP_001035241.1 | |
SCN3B | NM_018400.4 | c.389C>T | p.Ala130Val | missense_variant | Exon 3 of 6 | NP_060870.1 | ||
SCN3B | XM_011542897.3 | c.389C>T | p.Ala130Val | missense_variant | Exon 4 of 7 | XP_011541199.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251424Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135888
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461894Hom.: 1 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727248
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74310
ClinVar
Submissions by phenotype
Atrial fibrillation, familial, 16 Pathogenic:1
- -
not provided Uncertain:1
Reported in a 46-year-old individual from the Han Chinese population with lone atrial fibrillation (Wang et al., 2010); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Functional studies show the A130V variant decreased the cardiac sodium current density, but did not have a significant effect on the kinetics of activation, inactivation, and channel recovery from inactivation; however, when co-expressed with wild type SCN3B, A130V negated the function of wild type SCN3B (Wang et al., 2010); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23557754, 21937582, 23838598, 25668026, 25175087, 21454796, 20558140, 26728597) -
Brugada syndrome 7 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been reported to affect SCN3B protein function (PMID: 20558140). This variant has been observed in individual(s) with atrial fibrillation (PMID: 20558140). ClinVar contains an entry for this variant (Variation ID: 140597). This variant is present in population databases (rs587777556, ExAC 0.009%). This sequence change replaces alanine with valine at codon 130 of the SCN3B protein (p.Ala130Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at